BrainStorm Cell Therapeutics Inc. (BCLI):企業の財務及び戦略的SWOT分析

◆英語タイトル:BrainStorm Cell Therapeutics Inc. (BCLI) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH42156FSA
◆発行会社(調査会社):GlobalData
◆発行日:2016年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥32,400見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥64,800見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD900 ⇒換算¥97,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

BrainStorm Cell Therapeutics Inc. (BrainStorm) is a biotechnology company. It develops autologous stem cell therapies for debilitating neurodegenerative diseases, such as amyotrophic lateral sclerosis, multiple sclerosis and Parkinson’s disease. The company develops NurOwn technology for the propagation and differentiation of autologous mesenchymal stem cells (MSCs) into neurotrophic factor (NTF)-secreting cells and their transplantation at or near the site of damage. BrainStorm also develops cellular therapeutics based on stem cell technologies. It operates through its office located in Tel-Aviv, Israel. The company works in partnership with Hadassah Medical center, Octane Biotech and Dana Farber Cancer Institute. BrainStorm is headquartered in Hackensack, New Jersey the US.

BrainStorm Cell Therapeutics Inc. Key Recent Developments

Nov 17, 2015: BrainStorm Cell Therapeutics Reports Third Quarter 2015 Financial Results And Provides Corporate Update
Oct 07, 2015: BrainStorm Announces Treatment of Final Patient in US Multicenter Double Blinded Phase 2 ALS Trial
Sep 22, 2015: BrainStorm Announces Appointment of Chaim Lebovits as Chief Executive Officer
Aug 13, 2015: BrainStorm Cell Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update
Aug 03, 2015: BrainStorm Strengthens Executive Team: Announces the Appointment of Yoram Bibring as Chief Financial Officer

This comprehensive SWOT profile of BrainStorm Cell Therapeutics Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of BrainStorm Cell Therapeutics Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

BrainStorm Cell Therapeutics Inc. – Key Information
BrainStorm Cell Therapeutics Inc. – Overview
BrainStorm Cell Therapeutics Inc. – Key Employees
BrainStorm Cell Therapeutics Inc. – Key Employee Biographies
BrainStorm Cell Therapeutics Inc. – Key Operational Heads
BrainStorm Cell Therapeutics Inc. – Major Products and Services
BrainStorm Cell Therapeutics Inc. – History
BrainStorm Cell Therapeutics Inc. – Company Statement
BrainStorm Cell Therapeutics Inc. – Locations And Subsidiaries
BrainStorm Cell Therapeutics Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

BrainStorm Cell Therapeutics Inc. – Business Description
BrainStorm Cell Therapeutics Inc. – Corporate Strategy
BrainStorm Cell Therapeutics Inc. – SWOT Analysis
SWOT Analysis – Overview
BrainStorm Cell Therapeutics Inc. – Strengths
BrainStorm Cell Therapeutics Inc. – Weaknesses
BrainStorm Cell Therapeutics Inc. – Opportunities
BrainStorm Cell Therapeutics Inc. – Threats
BrainStorm Cell Therapeutics Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

BrainStorm Cell Therapeutics Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

BrainStorm Cell Therapeutics Inc., Key Information
BrainStorm Cell Therapeutics Inc., Key Ratios
BrainStorm Cell Therapeutics Inc., Share Data
BrainStorm Cell Therapeutics Inc., Major Products and Services
BrainStorm Cell Therapeutics Inc., History
BrainStorm Cell Therapeutics Inc., Key Employees
BrainStorm Cell Therapeutics Inc., Key Employee Biographies
BrainStorm Cell Therapeutics Inc., Key Operational Heads
BrainStorm Cell Therapeutics Inc., Other Locations
BrainStorm Cell Therapeutics Inc., Subsidiaries
BrainStorm Cell Therapeutics Inc., Key Manufacturing facilities
BrainStorm Cell Therapeutics Inc., Key Competitors
BrainStorm Cell Therapeutics Inc., SWOT Analysis
BrainStorm Cell Therapeutics Inc., Ratios based on current share price
BrainStorm Cell Therapeutics Inc., Annual Ratios
BrainStorm Cell Therapeutics Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

BrainStorm Cell Therapeutics Inc., Performance Chart
BrainStorm Cell Therapeutics Inc., Ratio Charts

★海外企業調査レポート[BrainStorm Cell Therapeutics Inc. (BCLI):企業の財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Constellation Energy Partners LLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Constellation Energy Partners L …
  • Western Mining Co. Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Western Mining Co. Ltd. Mergers …
  • Canon Medical Systems Corp:医療機器:M&Aディール及び事業提携情報
    Summary Canon Medical Systems Corp (Canon Medical Systems), formerly known as Toshiba Medical Systems Corp, a subsidiary of Canon Inc, is a provider of medical diagnostic systems and comprehensive medical solutions. The company’s product portfolio include computed tomography systems, magnetic resona …
  • Fluor Corporation:企業の戦略・SWOT・財務情報
    Fluor Corporation - Strategy, SWOT and Corporate Finance Report Summary Fluor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • SurgaColl Technologies Ltd:医療機器:M&Aディール及び事業提携情報
    Summary SurgaColl Technologies Ltd (SurgaColl Technologies) is a medical device company that develops novel tissue regeneration products for the surgical treatment of disease of the bone, cartilage and other human tissue. The company’s products include hydroxycoll and chondrocoll. Its hydroxycoll is …
  • Packages Limited:企業概要・SWOT・財務分析
    Summary Canadean's "Packages Limited : Paper and Packaging - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description …
  • KeyCorp:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' KeyCorp Mergers and Acquisition …
  • KT Corporation:企業の戦略・SWOT・財務情報
    KT Corporation - Strategy, SWOT and Corporate Finance Report Summary KT Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Quanta Services Inc (PWR):石油・ガス:M&Aディール及び事業提携情報
    Summary Quanta Services, Inc. (Quanta) is a specialized contracting services company that offers infrastructure solutions. It designs, installs, upgrades, repairs and maintains infrastructure of electric power transmission and distribution networks, substation facilities, renewable energy facilities …
  • Konecranes Plc:企業のM&A・提携・投資分析
    Konecranes Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Konecranes Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Genocea Biosciences Inc (GNCA):企業財務及び戦略的SWOT分析
    Summary Genocea Biosciences Inc (Genocea), formerly Genocea, Inc is a clinical stage biotechnology company that develops vaccines. The company discovers and develops novel vaccines for various infectious diseases. It conducts research and develops vaccines in the pre-clinical development stage for s …
  • IHS Inc.:企業のM&A・提携・投資分析
    IHS Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IHS Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Westlake Chemical Corporation:企業の戦略・SWOT・財務情報
    Westlake Chemical Corporation - Strategy, SWOT and Corporate Finance Report Summary Westlake Chemical Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Physio-Control Inc:企業のM&A・提携動向(医療機器分野)
    Summary Physio-Control Inc (Physio-Control), a subsidiary of Bain Capital LLC is a medical device company that offers development, manufacture, sale and service of emergency medical response products. The company offers pre-hospital, hospital, military, and accessory and disposable products. Its mil …
  • T&D Holdings, Inc. (8795):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "T&D Holdings, Inc." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follow …
  • Johnson & Johnson (JNJ):企業のM&A・提携動向(医療機器分野)
    Summary Johnson & Johnson (J&J) is a pharmaceutical holding company. It carries out the manufacture and sale of a wide range of pharmaceutical products and medical devices. It provides products for human health and well-being. J&J’s product offerings include consumer products comprising a wide range …
  • Q.E.P. Co., Inc. (QEPC):企業の財務及び戦略的SWOT分析
    Summary Q.E.P. Co., Inc. (Q.E.P.) is a manufacturer of building materials that offers flooring and industrial solutions. The company manufactures, markets and distributes specialty tools and flooring related products. Its products include adhesives, grouts and mortars, hardwood flooring, pneumatic n …
  • Seahorse Bioscience Inc.:企業のM&A・提携動向(医療機器分野)
    Summary Seahorse Bioscience Inc. (Seahorse), a subsidiary of Agilent Technologies, Inc. is a medical device company that provides analytical instruments, biomanufacturing systems and consumable labware products for biological research and drug discovery. The company’s products include Seahorse XF In …
  • Coca-Cola East Japan Co., Ltd:企業の戦略・SWOT・財務分析
    SummaryCoca-Cola East Japan Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compan …
  • PTT Public Company Limited (PTT)(エネルギー分野):企業M&A動向
    Summary PTT Public Company Limited (PTT) is an integrated petroleum and petrochemical company. The company, through its subsidiaries and associates carries out exploration, development and production of natural gas, condensate and crude oil besides managing petrochemical; refining; and retail sale a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆